Last reviewed · How we verify

Jianzhong Qushi Formula — Competitive Intelligence Brief

Jianzhong Qushi Formula (Jianzhong Qushi Formula) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

phase 3 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Jianzhong Qushi Formula (Jianzhong Qushi Formula) — Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Jianzhong Qushi Formula is a traditional Chinese medicine herbal compound designed to reduce tumor-associated ascites and improve quality of life in cancer patients.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Jianzhong Qushi Formula TARGET Jianzhong Qushi Formula Cancer Institute and Hospital, Chinese Academy of Medical Sciences phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Jianzhong Qushi Formula — Competitive Intelligence Brief. https://druglandscape.com/ci/jianzhong-qushi-formula. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: